Michael Munin
Physical Medicine and Rehabilitation · Pittsburgh, PANPI 1821062597
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,056 of the $42,811 with a category attached, or 93.6%. 7 manufacturers reported payments, led by AbbVie at 27.3% of the total. 2025 is the largest year on record at $11,610, more than ten times the $590 reported in 2019. Among physical medicine and rehabilitation clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $807.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- Ipsen Biopharmaceuticals, Inc$11K
- Merz Pharmaceuticals, LLC$10K
- Pacira Pharmaceuticals Incorporated$10K
- Merz North America, Inc.$394
- E.r. Squibb & Sons, L.L.C.$32
- plus $20 from 1 others
Across 118 payments — averaging $3145.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$140K
- Merz Pharmaceuticals, LLC$128K
- Merz North America, Inc.$44K
- Ipsen Pharma SAS$39K
- Pacira Pharmaceuticals Incorporated$21K
What the payments were for
- Consulting fees$40,05694%
- Travel & lodging$4481%
- Food & beverage$2,3085%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $11,700 |
| Ipsen Biopharmaceuticals, Inc | 6 | $10,941 |
| Merz Pharmaceuticals, LLC | 10 | $9,957 |
| Pacira Pharmaceuticals Incorporated | 15 | $9,767 |
| Merz North America, Inc. | 5 | $394 |
| E.r. Squibb & Sons, L.L.C. | 1 | $32 |
| Mylan Specialty L.p. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,811 in reported general payments places this provider in the 95th percentile of 550 physical medicine and rehabilitation providers in Pennsylvania.
See all physical medicine and rehabilitation providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 126 | $3,440 |
| Gabapentin | 146 | $2,024 |
| Pregabalin | 11 | $256 |
| Venlafaxine Hcl | 13 | $180 |
| Tizanidine Hcl | 32 | $153 |
| Lorazepam | 11 | $124 |
| Clonazepam | 13 | $101 |
| Cyclobenzaprine Hcl | 12 | $36 |
| Diazepam | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other physical medicine and rehabilitation in Pittsburgh
- Shelana Gibbs-McelvyPittsburgh$39K
- Alexander BehnazPittsburgh$18K
- Colton HickmanPittsburgh$9K
- Kentaro OnishiPittsburgh$6K
- Karl LiebePittsburgh$5K
- John LeePittsburgh$4K
- Thomas FranzPittsburgh$4K
- Jeffery RoweKing Of Prussia$1.9M
- Michael SaulinoElkins Park$425K
- Huaguang QuChalfont$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.